<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		xmlns:xhtml="http://www.w3.org/1999/xhtml"
	>
<channel>
	<title>Diabetes Management Market Research: Fast-Acting Human Insulin Market Share Rankings and Ultra-Rapid Formulation Growth (Fiasp® Up 12% YoY) – Key Players Novo Nordisk (44%), Eli Lilly (31%), Sanofi (19%) へのコメント</title>
	<atom:link href="https://tblo.tennis365.net/globaqyrresearchs/2026/06/03/diabetes-management-market-research-fast-acting-human-insulin-market-share-rankings-and-ultra-rapid-formulation-growth-fiasp-up-12-yoy-key-players-novo-nordisk-44-eli-lilly-31/feed/" rel="self" type="application/rss+xml" />
	<link>https://tblo.tennis365.net/globaqyrresearchs/2026/06/03/diabetes-management-market-research-fast-acting-human-insulin-market-share-rankings-and-ultra-rapid-formulation-growth-fiasp-up-12-yoy-key-players-novo-nordisk-44-eli-lilly-31/</link>
	<description></description>
	<lastBuildDate>Thu, 19 Mar 2026 05:54:45 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.5.1</generator>
</channel>
</rss>
